|
|
|
|
|
07.05.25 - 22:18
|
Cross Country Healthcare Announces First Quarter 2025 Financial Results (Business Wire)
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the Company) (Nasdaq: CCRN) today announced financial results for its first quarter ended March 31, 2025.
SELECTED FINANCIAL INFORMATION:
Variance
Variance
Q1 2025 vs
Q1 2025 vs
Dollars are in thousands, except per share amounts
Q1 2025
Q1 2024
Q4 2024
Revenue
$
293,408
(23
)
%
(5
)
%
Gross profit margin*
20.0
%
(40
)
bps
—
bps
Net loss attributable to common stockholders
$
(490
)
(118
)
%
87
%
Diluted EPS
$
(0.02
)
$
(0.10
)
$
0.10
Adjusted EBITDA*
$
8,619
(44
)
%
(7
)
%
Adjusted EBITDA margin*
2.9
%
(110
)
bps
(10
)
bps
Adjusted EPS*
$
0.06
$
(0.13
)
$
0.02
Cash flows provided by operations
$
5,681
(5
)
%
(77
)
%
* Represents amounts that are not calculated in accordance with U.S. generally accepted accounting principles (GAAP) and are referred to as non-GAAP measures. Please refer to the accompanying discussion b...
|
|
|
|
|
|
05.03.25 - 22:18
|
Cross Country Healthcare Announces Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (the “Company”) (Nasdaq: CCRN) today announced financial results for its fourth quarter and full year ended December 31, 2024.
SELECTED FINANCIAL INFORMATION:
Dollars are in thousands, except per share amounts
Q4 2024
Variance Q4 2024
vs Q4 2023
Variance Q4 2024
vs Q3 2024
Full Year 2024
Variance 2024
vs 2023
Revenue
$
309,940
(25
)
%
(2
)
%
$
1,344,004
(33
)
%
Gross profit margin*
20.0
%
(190
)
bps
(40
)
bps
20.4
%
(190
)
bps
Net loss attributable to common stockholders
$
(3,753
)
(142
)
%
(247
)
%
$
(14,556
)
(120
)
%
Diluted EPS
$
(0.12
)
$
(0.38
)
$
(0.20
)
$
(0.44
)
$
(2.49
)
Adjusted EBITDA*
$
9,271
(55
)
%
(10
)
%
$
49,073
(66
)
%
Adjusted EBITDA margin*
3.0
%
(200
)
bps
(30
)
bps
3.7
%
(350
)
bps
Adjusted EPS*
$
0.04
$
(0.25
)
$
(0.08
)
$
0.46
$
(1.77
)
Cash flows provided by operations
$
24,2...
|
|
|
|
28.02.25 - 22:51
|
Cross Country Healthcare Stockholders Approve Aya Healthcare Transaction (Business Wire)
|
|
BOCA RATON, Fla.--(BUSINESS WIRE)--Cross Country Healthcare, Inc. (“Cross Country” or the “Company”) (NASDAQ: CCRN) today announced that the Company has obtained all requisite stockholder approvals in connection with its proposed acquisition by Aya Healthcare.
As previously disclosed, Cross Country and Aya Healthcare expect to complete the transaction in the second half of 2025, subject to the satisfaction or waiver of customary closing conditions specified in the Merger Agreement. Upon completion of the transaction, Cross Country will become a private company and its common stock will no longer trade on the NASDAQ.
Cross Country will file the final, certified voting results on a Form 8-K with the U.S. Securities and Exchange Commission.
BofA Securities, Inc. is serving as financial advisor and Davis Polk & Wardwell LLP is serving as legal advisor to Cross Country.
About Cross Country Healthcare
Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm ...
|
|
|
|
|
|
04.12.24 - 16:52
|
Cross Country Healthcare rises over 60% on $615 mln take-private deal (Reuters EN)
|
|
BUZZ-Cross Country Healthcare rises over 60% on $615 mln take-private deal ** Clinical services provider Cross Country Healthcare's CCRN.O shares rise 62.7% to $18.16 ** CCRN says peer Aya Healthcare will buy it in an all-cash deal for $18.61 per share, representing a total equity value of about $615 mln ** Aya and CCRN will continue to operate as separate brands, the companies say ** After deal, CCRN will become a private company ** The deal represents a premium of 66.8% to CCRN's closing price...
|
|
|
|